首页> 外文期刊>Seminars in radiation oncology >An Overview of Hypofractionation and Introduction to This Issue of Seminars in Radiation Oncology
【24h】

An Overview of Hypofractionation and Introduction to This Issue of Seminars in Radiation Oncology

机译:超分割技术概述及本期放射肿瘤学研讨会简介

获取原文
获取原文并翻译 | 示例
       

摘要

To the classically trained radiation oncologist, the first thing that comes to mind when considering large dose per fraction radiation treatment is the concern for "late effects." Late effects, as the name implies, happen later than the effects of most medical therapies, actually months to years after completion of therapy. Aside from the knowledge of radiation-induced neoplasia, the idea of late effects is mostly foreign to our colleagues in surgery and internal medicine given that their therapies mostly cause "early effects" seen soon after administering a. drug or in the immediate postoperative period. Thorough knowledge of late effects belongs to the radiation oncologist more than any other specialty, and large dose per fraction treatment, also called hypofractionation, is more likely to cause late effects.
机译:对于受过经典训练的放射肿瘤学家而言,考虑按每小剂量进行大剂量放射治疗时,首先想到的是对“后期效应”的关注。顾名思义,后期效果要比大多数药物疗法的效果要晚,实际上是在治疗完成后数月至数年。除了了解辐射诱发的赘生性肿瘤以外,对于我们的外科和内科医学同事来说,迟发效应的观念在大多数情况下是陌生的,因为他们的治疗方法大多会导致“早期效应”的出现。药物或术后立即使用。放射肿瘤学家比其他任何专业人士都对后效应有透彻的了解,并且每部分大剂量治疗(也称为超分割)更可能导致后效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号